{"log_id": 9022987474098179427, "direction": 0, "words_result_num": 32, "words_result": [{"probability": {"variance": 0, "average": 0.999984, "min": 0.999981}, "location": {"width": 28, "top": 161, "height": 59, "left": 1119}, "words": "监证"}, {"probability": {"variance": 0.000466, "average": 0.99058, "min": 0.899217}, "location": {"width": 587, "top": 217, "height": 26, "left": 193}, "words": "拉法辛后,至少有92%被吸收。文拉法辛的绝对生物利用度约为45%"}, {"probability": {"variance": 0.002163, "average": 0.979252, "min": 0.757135}, "location": {"width": 737, "top": 262, "height": 27, "left": 232}, "words": "服用本品缓释胶囊(150mg,q24h)通常具有较低的峰浓度(文拉法辛和ODV分别为150"}, {"probability": {"variance": 0.00643, "average": 0.960296, "min": 0.668515}, "location": {"width": 780, "top": 305, "height": 36, "left": 193}, "words": "n/mL和260ng/mL),较迟的达峰时间(文拉法辛和ODV分别为5.5h和9h)。当每天服用的"}, {"probability": {"variance": 3.4e-05, "average": 0.997313, "min": 0.96528}, "location": {"width": 775, "top": 353, "height": 27, "left": 197}, "words": "文拉法辛剂量相同时,服用本品的患者血药浓度的波动明显较低。因此本品与常释片相比吸"}, {"probability": {"variance": 0.003722, "average": 0.965593, "min": 0.808787}, "location": {"width": 300, "top": 400, "height": 26, "left": 194}, "words": "收较慢,但是吸收的药物总量相同"}, {"probability": {"variance": 0.003105, "average": 0.980718, "min": 0.659849}, "location": {"width": 745, "top": 444, "height": 27, "left": 234}, "words": "使用75mg的本品时发现食物对文拉法辛和其活性代谢产物ODV的生物利用度没有影响,"}, {"probability": {"variance": 0.000411, "average": 0.988636, "min": 0.929709}, "location": {"width": 595, "top": 488, "height": 29, "left": 194}, "words": "服药时间(上午或下午)的不同也不影响文拉法辛和ODV的药物代谢"}, {"probability": {"variance": 0.000326, "average": 0.981845, "min": 0.954688}, "location": {"width": 103, "top": 536, "height": 23, "left": 196}, "words": "代谢排泄"}, {"probability": {"variance": 0.002619, "average": 0.985884, "min": 0.685825}, "location": {"width": 732, "top": 577, "height": 29, "left": 240}, "words": "文拉法辛吸收后在肝脏进行首过代谢,主要代谢产物为ODV,同时包括N去甲基文拉"}, {"probability": {"variance": 0.001979, "average": 0.975996, "min": 0.833288}, "location": {"width": 780, "top": 622, "height": 27, "left": 194}, "words": "法辛、N,O-去二甲基文拉法辛以及其它少量代谢产物。体外研究显示ODV是通过CYP2D6"}, {"probability": {"variance": 0.002091, "average": 0.989045, "min": 0.695236}, "location": {"width": 780, "top": 668, "height": 25, "left": 194}, "words": "酶的代谢产生的,临床研究也证实CYP2D活性低(慢代谢)的患者与具有正常CYP2D6活"}, {"probability": {"variance": 0.000555, "average": 0.990392, "min": 0.863646}, "location": {"width": 777, "top": 713, "height": 27, "left": 195}, "words": "性者相比具有较高的文拉法辛和较低的ODV药物浓度。因为在CYP2D6活性不同的两组患者"}, {"probability": {"variance": 0.004842, "average": 0.978366, "min": 0.5736}, "location": {"width": 758, "top": 758, "height": 25, "left": 196}, "words": "中,其文拉法辛和ODV的总量接近,而且ODV与文拉法辛具有相似的药理作用和作用强度"}, {"probability": {"variance": 3e-06, "average": 0.99873, "min": 0.994661}, "location": {"width": 376, "top": 802, "height": 24, "left": 196}, "words": "故这种代谢能力的不同并无重要的临床意义"}, {"probability": {"variance": 0.000276, "average": 0.99498, "min": 0.894225}, "location": {"width": 730, "top": 845, "height": 26, "left": 241}, "words": "在服用文拉法辛48小时后约有87%的药物经尿排出体外,其中包括5%的原型药、29%"}, {"probability": {"variance": 0.007647, "average": 0.970495, "min": 0.452453}, "location": {"width": 778, "top": 890, "height": 27, "left": 195}, "words": "非结合的ODV、26%结合的ODV和27%无活性的代谢产物。因而,文拉法辛及其代谢产物主"}, {"probability": {"variance": 0.000322, "average": 0.991895, "min": 0.947976}, "location": {"width": 140, "top": 937, "height": 25, "left": 198}, "words": "要通过肾脏排泄"}, {"probability": {"variance": 3.1e-05, "average": 0.995864, "min": 0.983953}, "location": {"width": 142, "top": 983, "height": 24, "left": 199}, "words": "特殊人群的应用"}, {"probability": {"variance": 0.000154, "average": 0.994737, "min": 0.934648}, "location": {"width": 736, "top": 1025, "height": 25, "left": 237}, "words": "年龄和性别:2项由404例患者参加的药动学研究显示,在每日服药2次和3次的患者"}, {"probability": {"variance": 0.004679, "average": 0.985483, "min": 0.562926}, "location": {"width": 773, "top": 1067, "height": 25, "left": 196}, "words": "中其文拉法辛和ODv的血药浓度均不受年龄和性别的影响。因此一般不必根据患者的年龄"}, {"probability": {"variance": 8e-06, "average": 0.998038, "min": 0.991422}, "location": {"width": 197, "top": 1113, "height": 25, "left": 199}, "words": "和性别调整药物的剂量"}, {"probability": {"variance": 0.002598, "average": 0.987805, "min": 0.669579}, "location": {"width": 734, "top": 1157, "height": 26, "left": 238}, "words": "快代谢/慢代谢者:CYP2D6活性较低的患者与快代谢的患者相比具有较高文拉法辛的血"}, {"probability": {"variance": 0.001842, "average": 0.987837, "min": 0.744928}, "location": {"width": 776, "top": 1200, "height": 27, "left": 197}, "words": "药浓度,因为文拉法辛和ODV的总AUC接近,因此也没有必要在这两组患者中采用不同的"}, {"probability": {"variance": 0, "average": 0.999168, "min": 0.999125}, "location": {"width": 42, "top": 1249, "height": 22, "left": 199}, "words": "剂量"}, {"probability": {"variance": 0.003668, "average": 0.981357, "min": 0.678942}, "location": {"width": 736, "top": 1290, "height": 26, "left": 236}, "words": "肝脏疾病:在9例伴有肝硬化的患者口服文拉法辛后,文拉法辛和ODV的药物代谢明显"}, {"probability": {"variance": 0.008101, "average": 0.976618, "min": 0.461032}, "location": {"width": 774, "top": 1333, "height": 28, "left": 199}, "words": "受到影响,肝硬化患者与健康者相比的文拉法辛的消除华衰期延长约30%,药物清除率下降"}, {"probability": {"variance": 0.001461, "average": 0.984993, "min": 0.799285}, "location": {"width": 773, "top": 1379, "height": 26, "left": 199}, "words": "50%,ODV的消除半衰期延长约60%,药物清除率下降30%。同时也注意到药物的清除率有"}, {"probability": {"variance": 4.1e-05, "average": 0.996797, "min": 0.968128}, "location": {"width": 685, "top": 1424, "height": 26, "left": 201}, "words": "更大的变化,3例较为严重的肝硬化患者文拉法辛的清除率下降更明显(约90%)"}, {"probability": {"variance": 1.3e-05, "average": 0.99826, "min": 0.986987}, "location": {"width": 294, "top": 1469, "height": 27, "left": 237}, "words": "在另一项研究中,在正常受试者中"}, {"probability": {"variance": 0.000667, "average": 0.98255, "min": 0.90517}, "location": {"width": 399, "top": 1469, "height": 23, "left": 573}, "words": "21)口服和静脉注射文拉法辛,按 Child-Pugh分"}, {"probability": {"variance": 0.018223, "average": 0.932063, "min": 0.463446}, "location": {"width": 775, "top": 1512, "height": 27, "left": 197}, "words": "级, Child- Pugh A级(na8), Child- Pugh B级(n=11(轻度和中度损害):文拉法辛口服"}], "language": 3}